Weight-loss drugs are an issue for McDonald’s, but here’s the bigger problem

McDonald’s stock was heading for its longest losing streak in 12 years after Redburn Atlantic recommended investors sell due to concerns over the impact of weight-loss drugs and relatively high prices.